Celyad SA Made Headway

Tue, Feb 07, 2023 at 07:08 PM
Celyad SA Made Headway

Celyad SA (CYAD:NASDAQ) soared at $1.5, representing a gain of 32.8%. On Tue, Feb 07, 2023, CYAD:NASDAQ hit a New 2-Week Intraday High of $1.85. The stock appeared on our News Catalysts scanner on Fri, Feb 03, 2023 at 03:02 AM in the 'INVESTOR UPDATE' category. From Tue, Jan 24, 2023, the stock recorded 30.00% Up Days and 27.27% Green Days

The stock spiked on Wed, Jan 18, 2023 at $3.07 with a volume of 20M+.

About Celyad SA (CYAD:NASDAQ)

Celyad SA is a biopharmaceutical company. The company is engaged in stem cell-based therapies for the treatment of cardiovascular diseases. It is developing therapeutic therapies based on two distinct technology platforms in cardiology and oncology.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.